Mutual Capital Partners is excited to announce that Quest Diagnostics will acquire Cleveland HeartLab and form a strategic partnership with the Cleveland Clinic. Cleveland HeartLab is a portfolio company in our second fund. We are proud of all the hard work that the Cleveland HeartLab team has put in to make this possible! Read more here

OrthAlign, Inc. announced it has raised $10 million in a series D financing round for product development as the company expands from a solution provider for total knee surgery to a platform technology provider for total knee, partial knee and total hip replacements, according to a company press release. Mutual Capital Partners is proud to be a part of that financing and to see OrthAlign continue to grow! Read more about it here